Many people using GLP-1 medication describe renewed energy, steady progress on the scale, and a sense of hope
Both Tirzepatide and Semaglutide (Ozempic) are once-weekly injections for the treatment of diabetes and obesity
The more context you give, the better the coaching - but whatever you share is up to you
Temporary soreness, redness, or bruising at the injection site Mild itching or swelling at the site Occasional nausea, headache, or lightheadedness shortly after injection Allergic reaction (uncommon) Infection at the injection site if sterile technique is compromised Nutrient imbalance with prolonged, unsupervised use particularly relevant for patients with kidney disease The FDA has warned against unapproved injectable products marketed for fat reduction, citing risks including infection, scarring, and skin deformities
which was recommended by my hairdresser